Workflow
Tandem Diabetes Care(TNDM)
icon
Search documents
Tandem Diabetes Care(TNDM) - 2022 Q1 - Quarterly Report
2022-05-04 20:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION For the Transition Period from to Commission File Number 001-36189 _____________________________________________________________________________________________ Tandem Diabetes Care, Inc. (Exact name of registrant as specified in its charter) _____________________________________________________________________________________________ Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q ...
Tandem Diabetes Care(TNDM) - 2021 Q4 - Earnings Call Transcript
2022-02-23 04:25
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2021 Earnings Conference Call February 22, 2022 4:30 PM ET Company Participants Susan Morrison - EVP and CAO John Sheridan - President and CEO Leigh Vosseller - EVP and CFO Brian Hansen - EVP and Chief Commercial Officer Conference Call Participants Chris Pasquale - Guggenheim Brooks O'Neil - Lake Street Capital Alex Nowak - Craig-Hallum Capital Steve Lichtman - Oppenheimer and Company Matthew O'Brien - Piper Sandler Matt Taylor - UBS Danielle Antalffy - SVB Leeri ...
Tandem Diabetes Care(TNDM) - 2021 Q4 - Annual Report
2022-02-22 21:11
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________________________ FORM 10-K _________________________________________________________________ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-36189 ______ ...
Tandem Diabetes Care(TNDM) - 2021 Q3 - Earnings Call Presentation
2021-11-04 09:16
Tandem Diabetes Care Company Overview NOVEMBER 3, 2021 Safe Harbor CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements, including, without limitation, statements about: the perceived advantages of our products relative to competitive products and technologies; our anticipated growth and other measures of future operating results and financial performance; the development and commercialization of new products; our ability to secur ...
Tandem Diabetes Care(TNDM) - 2021 Q3 - Earnings Call Transcript
2021-11-04 00:14
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q3 2021 Earnings Conference Call November 3, 2021 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer John Sheridan - President and Chief Executive Officer Leigh Vosseller - Executive Vice President and Chief Financial Officer Conference Call Participants Danielle Antalffy - SVB Leerink Matt Taylor - UBS Travis Steed - Barclays Brooks O'Neil - Lake Street Capital Alex Nowak - Craig-Hallum Capital Chris Pasquale - ...
Tandem Diabetes Care(TNDM) - 2021 Q3 - Quarterly Report
2021-11-03 20:13
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT ...
Tandem Diabetes Care(TNDM) - 2021 Q2 - Earnings Call Transcript
2021-08-05 01:44
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q2 2021 Earnings Conference Call August 4, 2021 4:30 PM ET Company Participants Susan Morrison – Executive Vice President and Chief Administrative Officer John Sheridan – President and Chief Executive Officer Brian Hansen – Executive Vice President and Chief Commercial Officer Leigh Vosseller – Executive Vice President and Chief Financial Officer Conference Call Participants Steven Lichtman – Oppenheimer and Company Rebecca Wang – SVB Leerink Travis Steed – Barclays ...
Tandem Diabetes Care(TNDM) - 2021 Q2 - Quarterly Report
2021-08-04 20:11
Table of contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________________________________________________ FORM 10-Q _____________________________________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1 ...
Tandem Diabetes Care (TNDM) Investor Presentation - Slideshow
2021-05-14 18:27
Tandem Diabetes Care Company Overview MAY 5, 2021 Safe Harbor CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS Certain statements in this presentation constitute forward-looking statements, including, without limitation, statements about: the perceived advantages of our products relative to competitive products and technologies; our anticipated growth and other measures of future operating results and financial performance; the development and commercialization of new products; our ability to secure and ...
Tandem Diabetes Care(TNDM) - 2021 Q1 - Earnings Call Transcript
2021-05-06 01:52
Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Susan Morrison - Executive Vice President and Chief Administrative Officer John Sheridan - President and Chief Executive Officer Leigh Vosseller - Executive Vice President and Chief Financial Officer. Conference Call Participants Steven Lichtman - Oppenheimer Larry Biegelsen - Wells Fargo Matthew O'Brien - Piper Sandler Brooks O'Neil - Lake Street Capital Matt Taylor - UBS Ravi Misra - Beren ...